MGI PHARMA, INC. (MOGN) Announces Change to Presentation Time at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Devices Conference
9/19/2007 11:48:29 AM
MINNEAPOLIS--(BUSINESS WIRE)--MGI PHARMA, INC. (Nasdaq:MOGN) today announced that the time of its presentation at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Devices Conference in London, England on Thursday, September 20, 2007 has been changed to 5:00 a.m. ET. Bill Spengler, Executive Vice President and Chief Financial Officer will provide an overview of the Company, its products, pipeline and 2007 corporate goals.
comments powered by